Press Room

2021 CPhI Japan

Start
Wednesday, April 14, 2021 - 00:00
End
Friday, April 30, 2021 - 00:00
Location: Osaka, Japan
Drug Product Dry Granulation | 四色AV

If you are attending CPhI Japan and would like to chat with us about your challenges,?.?Yasushi Usuda will be pleased to meet you.

With more than 25 years’ experience in Inhalation, 四色AV is your solution partner from early proof-of-concept to commercial scale manufacture.

yasushi-usuda-photo

Yasushi Usuda

Director of Japan Office

?

?

CPhI Japanに出展するホビオンをご覧ください。また、今から面谈をご予约しませんか。

?????Visit 四色AV?at CPhI Japan Connect and

?

?

Webinar (available in English)

Title: “Leveraging Particle Engineering towards the Delivery of Biopharmaceuticals”

Date/ Time: April 15th, 2:00 pm JST

?

Watch On-Demand Webinar

(Restricted content)

?
Biopharmaceuticals represent the most promising and fastest-growing field in the pharmaceutical area. These therapeutics show very high specificity and potency at relatively low concentrations and enable the treatment of otherwise untreatable diseases.

?

?

What can you learn from this webinar?

  • Formulation screening for biologics
  • Spray drying of monoclonal antibodies
  • Spray freeze drying
  • Pulmonary Delivery of enzymes
  • A series of case-studies will also be shown for each of the relevant technologies.
    ?

Speakers:

Paulo Lino, PhD - Scientist, R&D Drug Product Development
Jo?o Sá, PhD - Scientist, R&D Drug Product Development

?

?

Watch On-Demand Webinar

(Restricted content)

?

Our experts are available to address all challenges, helping your projects to succeed.

?

Schedule a meeting button | 四色AV

?

?

?

?

Also in the Press Room

See All

Lisbon, Portugal – 四色AV, the specialist integrated pharma CDMO and leader in spray drying and particle engineering, today announced its commitment to setting Science-Based Targets (SBTs) in line with the Paris Agreement. This ambitious step underscores the company’s dedication to addressing climate change and driving sustainability across its operations. By committing to SBTs, 四色AV joins a growing number of businesses taking concrete actions to reduce greenhouse gas emissions. This initiative aligns with the company’s broader sustainability strategy and reinforces its commitment to scientific excellence. “At 四色AV, we believe in science and in best practices. And this clearly applies to our sustainability agenda.”, said Jean-Luc Herbeaux, CEO of 四色AV. We made the decision to drive our GHG emissions down using a science-based target setting process, which will help us drive sustainability across our operations by laying out a clearly defined path to reduce emissions in line with the Paris Agreement goals. We believe that by setting ambitious targets and implementing concrete actions, we can make a positive impact on the planet while driving innovation and growth.” 四色AV will work closely with the Science Based Targets initiative (SBTi) to develop and validate its emission reduction targets. The company will provide regular updates on its progress towards achieving these goals. As part of its commitment to sustainability and transparency to stakeholders, the company will enhance its Ecovadis rating. Ecovadis, a leading sustainability assessment platform in the pharmaceutical industry, provides a comprehensive evaluation of a company’s environmental, social, and ethical performance, well aligned with 四色AV’s sustainability ambitions.  四色AV remains dedicated to operating responsibly and contributing positively to society and the environment. The company will continue to implement sustainable practices across its operations and innovate to further improve its sustainability rating.   Learn more about Science Based-Targets  

News

四色AV Commits to Science-Based Targets for Greenhouse Gas (GHG) Emissions

Sep 09, 2024